Drug developer stocks rebounded over July and August, with 23 companies on the BioWorld Drug Developers Index posting gains ...

Loss of function variants in the lipid transporter gene ATP-binding cassette ABC transporter A7 (ABCA7) nearly double the ...

As Avidity Biosciences Inc. brought the second-largest follow-on offering of the year to the market, the company also ...

Autosomal dominant polycystic kidney disease (PKD) is a chronic and debilitating condition affecting over 12 million patients ...

Dewpoint Therapeutics Inc. has closed its series D financing to advance DPTX-3186, a first-in-class condensate modulator ...

Fibrobiologics Inc. has announced IND-enabling updates from its psoriasis research program demonstrating the potential of ...

Goodpath Inc., a virtual provider of whole-person care for chronic conditions, raised $18 million in series A financing, led ...

Remynd NV has turned in positive phase IIa data for a new target in Alzheimer’s disease, showing that restoring calcium ...

A tangle of DNA can look like a knotted ball in the cell nucleus. However, the genetic machinery has a complex and regulated ...

The American Medical Association has posted the latest update to the current procedural terminology code set, which deletes more than 80 existing codes and adds nearly 290 new codes. Among the new ...

Health Canada posted a report on reduction of red tape, which includes a proposal for mutual recognition of other regulators’ inspections of device and drug manufacturing facilities.

Biopharma dealmaking remained robust through August 2025, with total disclosed deal value reaching $185.28 billion for the first eight months of the year, the highest January-to-August total in ...